108 related articles for article (PubMed ID: 34225249)
21. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
Keikes L; Koopman M; Lemmens VEPP; VAN Oijen MGH; Punt CJA
Anticancer Res; 2020 Aug; 40(8):4331-4341. PubMed ID: 32727761
[TBL] [Abstract][Full Text] [Related]
22. A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer.
Patel SV; Zhang L; Wei XS; Merchant SJ; Nanji S; James PD; Booth CM
Dis Colon Rectum; 2020 Mar; 63(3):336-345. PubMed ID: 32045399
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience.
Peng J; Li W; Zhang R; Lin J; Tang J; Wen Y; Lu Z; Wu X; Pan Z
Cancer Commun (Lond); 2019 Oct; 39(1):59. PubMed ID: 31619288
[TBL] [Abstract][Full Text] [Related]
24. Descriptive study comparing routine hospital administrative data with the Vascular Society of Great Britain and Ireland's National Vascular Database.
Aylin P; Lees T; Baker S; Prytherch D; Ashley S
Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):461-5; discussion 466. PubMed ID: 17175183
[TBL] [Abstract][Full Text] [Related]
25. Validation of the Hospital Episode Statistics Outpatient Dataset in England.
Thorn JC; Turner E; Hounsome L; Walsh E; Donovan JL; Verne J; Neal DE; Hamdy FC; Martin RM; Noble SM
Pharmacoeconomics; 2016 Feb; 34(2):161-8. PubMed ID: 26386702
[TBL] [Abstract][Full Text] [Related]
26. Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: A national population-based evaluation.
Boyle JM; van der Meulen J; Kuryba A; Cowling TE; Booth C; Fearnhead NS; Braun MS; Walker K; Aggarwal A
Eur J Cancer; 2023 Jan; 178():191-204. PubMed ID: 36459767
[TBL] [Abstract][Full Text] [Related]
27. Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data.
Amlani A; Kumar A; Ruan JY; Cheung WY
Cancer Med; 2016 Aug; 5(8):1776-82. PubMed ID: 27228415
[TBL] [Abstract][Full Text] [Related]
28. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.
Pandor A; Eggington S; Paisley S; Tappenden P; Sutcliffe P
Health Technol Assess; 2006 Nov; 10(41):iii-iv, xi-xiv, 1-185. PubMed ID: 17049138
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study.
Gibson AJW; Li H; D'Silva A; Elegbede AA; Tudor RA; Otsuka S; Bebb DG; Cheung WY
Lung Cancer; 2019 Aug; 134():141-146. PubMed ID: 31319972
[TBL] [Abstract][Full Text] [Related]
30. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
[TBL] [Abstract][Full Text] [Related]
31. Impact of Anatomic Extent of Nodal Metastasis on Adjuvant Chemotherapy Outcomes in Stage III Colon Cancer.
Woo IT; Park JS; Kang BW; Park SY; Kim HJ; Choi GS; Gwang Kim J
Dis Colon Rectum; 2020 Oct; 63(10):1455-1465. PubMed ID: 32969889
[TBL] [Abstract][Full Text] [Related]
32. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
33. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.
Lin CC; Bruinooge SS; Kirkwood MK; Olsen C; Jemal A; Bajorin D; Giordano SH; Goldstein M; Guadagnolo BA; Kosty M; Hopkins S; Yu JB; Arnone A; Hanley A; Stevens S; Hershman DL
J Clin Oncol; 2015 Oct; 33(28):3177-85. PubMed ID: 26304878
[TBL] [Abstract][Full Text] [Related]
34. Stratification of Stage III colon cancer may identify a patient group not requiring adjuvant chemotherapy.
Malik YG; Lyckander LG; Lindstrøm JC; Vinge-Holmquist O; Sheikh AE; Schultz JK; Ignjatovic D
J Cancer Res Clin Oncol; 2021 Jan; 147(1):61-71. PubMed ID: 32924067
[TBL] [Abstract][Full Text] [Related]
35. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada.
Lima IS; Yasui Y; Scarfe A; Winget M
Cancer; 2011 Aug; 117(16):3833-40. PubMed ID: 21319156
[TBL] [Abstract][Full Text] [Related]
36. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
Panchal JM; Lairson DR; Chan W; Du XL
Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
[TBL] [Abstract][Full Text] [Related]
37. Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan.
Minami K; Morita M; Emi Y; Okamoto M; Tanaka E; Nagata S; Touyama T; Ohgaki K; Tanaka T; Okumura H; Suenaga T; Tokunaga S; Oki E; Kakeji Y; Akagi Y; Baba H; Natsugoe S; Maehara Y;
Int J Clin Oncol; 2017 Jun; 22(3):505-510. PubMed ID: 28101757
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
39. Upgrading the SACT dataset and EBMT registry to enable outcomes-based reimbursement in oncology in England: a gap analysis and top-level cost estimate.
Jørgensen J; Kefalas P
J Mark Access Health Policy; 2019; 7(1):1635842. PubMed ID: 31303982
[No Abstract] [Full Text] [Related]
40. Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer: A Systematic Review and Meta-analysis.
Boyne DJ; Cuthbert CA; O'Sullivan DE; Sajobi TT; Hilsden RJ; Friedenreich CM; Cheung WY; Brenner DR
JAMA Netw Open; 2019 May; 2(5):e194154. PubMed ID: 31099875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
